Toradol, whose generic name is ketorolac tromethamine, belongs to the nonsteroidal anti-inflammatory drug (NSAID) class. It’s a potent analgesic and anti-inflammatory agent, distinct from opioids.
Chemical Structure and Properties
Ketorolac’s chemical structure features a propionic acid derivative. This contributes to its ability to inhibit cyclooxygenase (COX) enzymes.
Mechanism of Action
Toradol works by inhibiting both COX-1 and COX-2 enzymes. This action reduces the production of prostaglandins, which are inflammatory mediators involved in pain and swelling. Reduced prostaglandin production leads to pain relief and anti-inflammatory effects. Specifically:
- COX-1 inhibition contributes to its analgesic and anti-inflammatory effects but also accounts for some gastrointestinal side effects. COX-2 inhibition primarily contributes to its anti-inflammatory and analgesic effects.
This dual inhibition differentiates it from some newer NSAIDs that selectively target COX-2. The balance between COX-1 and COX-2 inhibition dictates Toradol’s therapeutic profile and potential side effects.
Pharmacokinetic Considerations
Toradol is administered intravenously, intramuscularly, or orally. Absorption varies based on the route of administration. Intravenous administration provides rapid onset of action. It undergoes hepatic metabolism and is primarily excreted through the kidneys.
Understanding Toradol’s chemical classification and mechanism of action helps clinicians appropriately utilize this medication and manage potential adverse effects.
